Lambert JC - Search Results

1

Effect of the APOE promoter polymorphisms on cerebral amyloid peptide deposition in Alzheimer's disease.

Lambert JC, Mann D, Goumidi L, Harris J, Amouyel P, Iwatsubo T, Lendon C, Chartier-Harlin MC. Lambert JC, et al. Lancet. 2001 Feb 24;357(9256):608-9. doi: 10.1016/S0140-6736(00)04063-0. Lancet. 2001. PMID: 11558492

2

Presenilin-1 polymorphism and Alzheimer's disease. The Alzheimer's Study Group.

Pérez-Tur J, Wavrant-De Vrieze F, Lambert JC, Chartier-Harlin MC. Pérez-Tur J, et al. Among authors: lambert jc. Lancet. 1996 Jun 1;347(9014):1560-1. Lancet. 1996. PMID: 8684137 No abstract available.

3

Analysis of the APOE alleles impact in Down's syndrome.

Lambert JC, Pérez-Tur J, Dupire MJ, Delacourte A, Frigard B, Chartier-Harlin MC. Lambert JC, et al. Neurosci Lett. 1996 Dec 6;220(1):57-60. doi: 10.1016/s0304-3940(96)13244-4. Neurosci Lett. 1996. PMID: 8977148

4

Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease.

Wavrant-DeVrièze F, Pérez-Tur J, Lambert JC, Frigard B, Pasquier F, Delacourte A, Amouyel P, Hardy J, Chartier-Harlin MC. Wavrant-DeVrièze F, et al. Among authors: lambert jc. Neurosci Lett. 1997 May 9;227(1):68-70. doi: 10.1016/s0304-3940(97)00304-2. Neurosci Lett. 1997. PMID: 9178861

5

Distortion of allelic expression of apolipoprotein E in Alzheimer's disease.

Lambert JC, Pérez-Tur J, Dupire MJ, Galasko D, Mann D, Amouyel P, Hardy J, Delacourte A, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 1997 Nov;6(12):2151-4. doi: 10.1093/hmg/6.12.2151. Hum Mol Genet. 1997. PMID: 9328480

6

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease.

Lambert JC, Pasquier F, Cottel D, Frigard B, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 1998 Mar;7(3):533-40. doi: 10.1093/hmg/7.3.533. Hum Mol Genet. 1998. PMID: 9467014

7

Association at LRP gene locus with sporadic late-onset Alzheimer's disease.

Lambert JC, Wavrant-De Vrièze F, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Lancet. 1998 Jun 13;351(9118):1787-8. doi: 10.1016/s0140-6736(05)78749-3. Lancet. 1998. PMID: 9635959 No abstract available.

8

Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease.

Lambert JC, Berr C, Pasquier F, Delacourte A, Frigard B, Cottel D, Pérez-Tur J, Mouroux V, Mohr M, Cécyre D, Galasko D, Lendon C, Poirier J, Hardy J, Mann D, Amouyel P, Chartier-Harlin MC. Lambert JC, et al. Hum Mol Genet. 1998 Sep;7(9):1511-6. doi: 10.1093/hmg/7.9.1511. Hum Mol Genet. 1998. PMID: 9700208

9

No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease.

Wavrant-DeVrièze F, Rudrasingham V, Lambert JC, Chakraverty S, Kehoe P, Crook R, Amouyel P, Wu W, Holmans P, Rice F, Pérez-Tur J, Frigard B, Morris JC, Carty S, Cottel D, Tunstall N, Lovestone S, Petersen RC, Chartier-Harlin MC, Goate A, Owen MJ, Williams J, Hardy J. Wavrant-DeVrièze F, et al. Among authors: lambert jc. Neurosci Lett. 1999 Mar 5;262(2):137-9. doi: 10.1016/s0304-3940(99)00035-x. Neurosci Lett. 1999. PMID: 10203250

10

A new GTP-cyclohydrolase I mutation in an unusual dopa-responsive dystonia, familial form.

Brique S, Destée A, Lambert JC, Mouroux V, Delacourte A, Amouyel P, Chartier-Harlin MC. Brique S, et al. Among authors: lambert jc. Neuroreport. 1999 Feb 25;10(3):487-91. doi: 10.1097/00001756-199902250-00008. Neuroreport. 1999. PMID: 10208576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters